Title : Deceleration of the neurodegenerative phenotype in pyroglutamate-Aβ accumulating transgenic mice by oral treatment with the Aβ oligomer eliminating compound RD2.

Pub. Date : 2019 Apr

PMID : 30391539






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Deceleration of the neurodegenerative phenotype in pyroglutamate-Abeta accumulating transgenic mice by oral treatment with the Abeta oligomer eliminating compound RD2. Pyrrolidonecarboxylic Acid amyloid beta (A4) precursor protein Mus musculus
2 Deceleration of the neurodegenerative phenotype in pyroglutamate-Abeta accumulating transgenic mice by oral treatment with the Abeta oligomer eliminating compound RD2. Pyrrolidonecarboxylic Acid amyloid beta (A4) precursor protein Mus musculus
3 Here, we report on the in vitro and in vivo efficacy of the compound towards pyroglutamate-Abeta, a particular aggressive Abeta species. Pyrrolidonecarboxylic Acid amyloid beta (A4) precursor protein Mus musculus
4 Here, we report on the in vitro and in vivo efficacy of the compound towards pyroglutamate-Abeta, a particular aggressive Abeta species. Pyrrolidonecarboxylic Acid amyloid beta (A4) precursor protein Mus musculus